2m 2m 2m 2m 2m 2m 2m
BENITEC BIOPHRM (BNTC)
NASDAQ
$8.99-$0.59 (-6.16%)
Price as of Oct 02, 2026 4:10 PM EDT- $334.2MMarket Cap
- -30.17%1-Year Change
- BiotechnologyIndustry
BENITEC BIOPHRM (BNTC)
$8.99-$0.59 (-6.16%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 0 +100.00% | -1,000 -66.67% | -3,000 -105.08% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 +100.00% | -1,000 -66.67% | -3,000 -105.08% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -23.4M +27.58% | -18.3M +17.45% | -15.6M +22.19% | -12.8M +81.97% | |
Depreciation and Amortization Expense | 58,000 -12.12% | 66,000 -24.14% | 87,000 -36.03% | 136,000 -41.13% | |
Total Operating Expenses | 51.2M +22.57% | 41.8M +85.70% | 22.5M +17.40% | 19.2M +40.29% | |
Operating Profit | -51.2M +22.57% | -41.8M +85.70% | -22.5M +17.87% | -19.1M +40.34% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -33,000 +450.00% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -33,000 +450.00% | |
Total Nonoperating Income and Expense | 5.6M +46.73% | 3.8M +420.70% | 739,000 +253.64% | -481,000 +68.18% | |
Income before Taxes | -45.5M +20.12% | -37.9M +69.50% | -22.4M +17.24% | -19.1M +40.34% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -45.5M +20.12% | -37.9M +74.32% | -21.8M +11.19% | -19.6M +40.92% | |
Net Income from Continuing Operations Applicable to Common | -45.5M +20.12% | -37.9M +69.50% | -22.4M +14.35% | -19.6M +40.92% | |
Basic EPS and Net Income | -0.98 -6.67% | -1.05 -80.94% | -5.51 -60.98% | -14.12 +337.15% | |
Diluted EPS and Net Income | -0.98 -6.67% | -1.05 -80.94% | -5.51 -60.98% | -14.12 +337.15% | |
Basic Weighted Average Shares | 46.6M +28.58% | 36.2M +791.81% | 4.1M +192.98% | 1.4M -67.74% | |
Diluted Weighted Average Shares | 46.6M +28.58% | 36.2M +791.81% | 4.1M +192.98% | 1.4M -67.74% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 180.0M +84.13% | 97.7M +92.16% | 50.9M +1,953.53% | 2.5M -87.47% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 180.0M +84.13% | 97.7M +92.16% | 50.9M +1,953.53% | 2.5M -87.47% | |
Total Current Assets | 181.7M +84.42% | 98.5M +90.65% | 51.7M +1,285.73% | 3.7M -81.91% | |
Accumulated Depreciation | 1.3M -10.48% | 1.5M +4.70% | 1.4M +6.53% | 1.3M +29.47% | |
Property and Plant and Equipment and Net | 178,000 +35.88% | 131,000 -26.82% | 179,000 +105.75% | 87,000 -76.80% | |
Total Long-Term Assets | 178,000 +35.88% | 131,000 -26.82% | 179,000 +105.75% | 87,000 -52.97% | |
Total Assets | 182.6M +83.37% | 99.6M +90.75% | 52.2M +1,069.58% | 4.5M -79.12% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 5.3M +196.56% | 1.8M -63.40% | 4.9M +23.78% | 4.0M +190.58% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 266,000 -46.26% | 495,000 N/A | 0 -100.00% | 284,000 +33.33% | |
Total Liabilities | 5.6M +144.23% | 2.3M -53.71% | 5.0M +16.42% | 4.3M +211.32% | |
Retained Earnings | -273.7M +19.96% | -228.2M +19.93% | -190.3M +13.32% | -167.9M +29.03% | |
Total Stockholders Equity | 177.0M +81.93% | 97.3M +105.92% | 47.2M +23,290.10% | 202,000 -98.99% | |
Total Shares Outstanding | 34.4M +31.11% | 26.3M +1,470.49% | 1.7M +1.55% | 1.6M -79.86% | |
Cash Flow | |||||
Cash from Operating Activities | -16.5M -29.97% | -23.6M +21.57% | -19.4M +7.72% | -18.0M +40.37% | |
Capital Expenditures | 105,000 +483.33% | 18,000 -89.94% | 179,000 +17,800.00% | 1,000 -99.55% | |
Cash from Investing Activities | -105,000 +483.33% | -18,000 -89.94% | -179,000 +17,800.00% | -1,000 -99.55% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 99.0M +40.42% | 70.5M +3.61% | 68.0M +324.78% | 16.0M -28.89% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | 2,249,000.00% +253.60% | 636,033.33% N/A | |
Return on Assets | -32.28% N/A | N/A N/A | -76.76% -49.30% | -151.39% N/A | |
Return on Equity | -33.21% N/A | N/A N/A | -91.68% -52.64% | -193.57% N/A | |
Revenue Growth | N/A N/A | N/A N/A | 66.67% +163.44% | -105.08% N/A | |
Current Ratio | 34.00 N/A | N/A N/A | 10.49 +1,019.51% | 0.94 N/A | |
Cash Ratio | 33.68 N/A | N/A N/A | 10.33 +1,558.94% | 0.62 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow